149 related articles for article (PubMed ID: 14612915)
1. Study of in vitro and in vivo effects of 1,6-Bis[4-(4-amino-3-hydroxyphenoxy)phenyl]diamantane (DPD), a novel cytostatic and differentiation inducing agent, on human colon cancer cells.
Wang JJ; Chang YF; Chern YT; Chi CW
Br J Cancer; 2003 Nov; 89(10):1995-2003. PubMed ID: 14612915
[TBL] [Abstract][Full Text] [Related]
2. The antitumor effect of a novel differentiation inducer, 2, 2-Bis (4-(4-amino-3-hydroxyphenoxy) phenyl) adamantane (DPA), in combinatory therapy on human colon cancer.
Wang JJ; Lee JY; Chen YC; Chern YT; Chi CW
Int J Oncol; 2006 Apr; 28(4):1003-12. PubMed ID: 16525652
[TBL] [Abstract][Full Text] [Related]
3. Role of p21 as a determinant of 1,6-Bis[4-(4-amino-3-hydroxyphenoxy)phenyl] diamantane response in human HCT-116 colon carcinoma cells.
Wang JJ; Hung HF; Huang ML; Lee HJ; Chern YT; Chang YF; Chi CW; Hsu YC
Oncol Rep; 2012 Feb; 27(2):529-34. PubMed ID: 22076474
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo growth inhibition and G1 arrest in human cancer cell lines by diaminophenyladamantane derivatives.
Wang JJ; Chen YC; Chi CW; Huang KT; Chern YT
Anticancer Drugs; 2004 Aug; 15(7):697-705. PubMed ID: 15269601
[TBL] [Abstract][Full Text] [Related]
5. Effects of 1, 6-Bis[4-(4-amino-3-hydroxyphenoxy)phenyl]diamantane (DPD), a reactive oxygen species and apoptosis inducing agent, on human leukemia cells in vitro and in vivo.
Chang YF; Chi CW; Chern YT; Wang JJ
Toxicol Appl Pharmacol; 2005 Jan; 202(1):1-12. PubMed ID: 15589971
[TBL] [Abstract][Full Text] [Related]
6. Induction of growth inhibition and G1 arrest in human cancer cell lines by relatively low-toxic diamantane derivatives.
Wang JJ; Huang KT; Chern YT
Anticancer Drugs; 2004 Mar; 15(3):277-86. PubMed ID: 15014362
[TBL] [Abstract][Full Text] [Related]
7. 1,6-Bis[4-(4-amino-3-hydroxyphenoxy)phenyl] diamantane potentiates
Yang PS; Wang JJ; Wang YH; Jan WC; Cheng SP; Hsu YC
Oncol Lett; 2016 May; 11(5):3551-3557. PubMed ID: 27123150
[TBL] [Abstract][Full Text] [Related]
8. Treatment of human colon cancer xenografts with TRA-8 anti-death receptor 5 antibody alone or in combination with CPT-11.
Oliver PG; LoBuglio AF; Zinn KR; Kim H; Nan L; Zhou T; Wang W; Buchsbaum DJ
Clin Cancer Res; 2008 Apr; 14(7):2180-9. PubMed ID: 18381960
[TBL] [Abstract][Full Text] [Related]
9. Anticolorectal cancer effects and pharmacokinetic application of 2, 2-Bis [4-(4-amino-3-hydroxyphenoxy) phenyl] adamantane.
Yang PS; Wang JJ; Tsai TH; Wang YH; Jan WC; Cheng SP; Chi CW; Hsu YC
Int J Clin Exp Med; 2015; 8(9):14805-15. PubMed ID: 26628962
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of recombinant methioninase in combination with cisplatin on human colon tumors in nude mice.
Tan Y; Sun X; Xu M; Tan X; Sasson A; Rashidi B; Han Q; Tan X; Wang X; An Z; Sun FX; Hoffman RM
Clin Cancer Res; 1999 Aug; 5(8):2157-63. PubMed ID: 10473100
[TBL] [Abstract][Full Text] [Related]
11. Antitumor activity of 2-chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl) adenine, a novel deoxyadenosine analog, against human colon tumor xenografts by oral administration.
Takahashi T; Kanazawa J; Akinaga S; Tamaoki T; Okabe M
Cancer Chemother Pharmacol; 1999; 43(3):233-40. PubMed ID: 9923554
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of histone deacetylases by trans-cinnamic acid and its antitumor effect against colon cancer xenografts in athymic mice.
Zhu B; Shang B; Li Y; Zhen Y
Mol Med Rep; 2016 May; 13(5):4159-66. PubMed ID: 27035417
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D2 analog 19-nor-1,25-dihydroxyvitamin D2: antitumor activity against leukemia, myeloma, and colon cancer cells.
Kumagai T; O'Kelly J; Said JW; Koeffler HP
J Natl Cancer Inst; 2003 Jun; 95(12):896-905. PubMed ID: 12813173
[TBL] [Abstract][Full Text] [Related]
14. Study of the antitumor mechanisms of apiole derivatives (AP-02) from Petroselinum crispum through induction of G0/G1 phase cell cycle arrest in human COLO 205 cancer cells.
Wu KH; Lee WJ; Cheng TC; Chang HW; Chen LC; Chen CC; Lien HM; Lin TN; Ho YS
BMC Complement Altern Med; 2019 Jul; 19(1):188. PubMed ID: 31351461
[TBL] [Abstract][Full Text] [Related]
15. Molecular mechanisms of econazole-induced toxicity on human colon cancer cells: G0/G1 cell cycle arrest and caspase 8-independent apoptotic signaling pathways.
Ho YS; Wu CH; Chou HM; Wang YJ; Tseng H; Chen CH; Chen LC; Lee CH; Lin SY
Food Chem Toxicol; 2005 Oct; 43(10):1483-95. PubMed ID: 15919146
[TBL] [Abstract][Full Text] [Related]
16. Anticancer effects of low-dose 10-hydroxycamptothecin in human colon cancer.
Ping YH; Lee HC; Lee JY; Wu PH; Ho LK; Chi CW; Lu MF; Wang JJ
Oncol Rep; 2006 May; 15(5):1273-9. PubMed ID: 16596197
[TBL] [Abstract][Full Text] [Related]
17. Dimethyladamantylmaleimide-induced in vitro and in vivo growth inhibition of human colon cancer Colo205 cells.
Wang JJ; Chern YT; Chang YF; Liu TY; Chi CW
Anticancer Drugs; 2002 Jun; 13(5):533-43. PubMed ID: 12045465
[TBL] [Abstract][Full Text] [Related]
18. Bisimidazoacridones and related compounds: new antineoplastic agents with high selectivity against colon tumors.
Cholody WM; Hernandez L; Hassner L; Scudiero DA; Djurickovic DB; Michejda CJ
J Med Chem; 1995 Aug; 38(16):3043-52. PubMed ID: 7636867
[TBL] [Abstract][Full Text] [Related]
19. Combination of gastrin-releasing peptide antagonist with cytotoxic agents produces synergistic inhibition of growth of human experimental colon cancers.
Rick FG; Buchholz S; Schally AV; Szalontay L; Krishan A; Datz C; Stadlmayr A; Aigner E; Perez R; Seitz S; Block NL; Hohla F
Cell Cycle; 2012 Jul; 11(13):2518-25. PubMed ID: 22751419
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of DMP 840: a novel bis-naphthalimide cytotoxic agent with human solid tumor xenograft selectivity.
McRipley RJ; Burns-Horwitz PE; Czerniak PM; Diamond RJ; Diamond MA; Miller JL; Page RJ; Dexter DL; Chen SF; Sun JH
Cancer Res; 1994 Jan; 54(1):159-64. PubMed ID: 8261436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
